Class of 2025San Francisco, CA
Immunotherapies for Breast Cancer
Started Dec. 30, 2022
Abstract or project description
Breast cancer affects around 1 in 3 women, making it the second most common cancer in females after skin cancer. Despite advancements in traditional treatment options such as surgery, chemotherapy, and radiotherapy, many patients still suffer from disease recurrence and progression. This has led to an increasing interest in alternative approaches, such as immunotherapy, which harnesses the power of the body's own immune system to fight cancer. This research paper highlights the growing importance of immunotherapy in the treatment of breast cancer and emphasizes the need for further research and clinical trials to fully understand its potential. While immunotherapy is still early in its development, especially for breast cancer, lots of research suggests that it holds promise as a safe and effective treatment option for patients who have not responded to traditional treatments or who have advanced-stage disease.